Status:

RECRUITING

Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes

Lead Sponsor:

Médipôle Lyon-Villeurbanne

Conditions:

Diabetes Mellitus, Type 2

Obesity

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Surgery is one of the management options for type 2 diabetes in patients with moderate obesity. This is a recent option because it has been part of the recommendations since October 2022. The possibl...

Eligibility Criteria

Inclusion

  • adult patient and ≤ 65 years old
  • T2D patient, with individualized glycemic objectives not achieved, despite medical care, in particular diabetological and nutritional, also including adapted physical activity, well conducted according to current good practice recommendations, for at least twelve months
  • BMI between 30 and 34.9 kg/m²
  • patient well informed beforehand about metabolic surgery and the study
  • multidisciplinary evaluation (including a diabetologist) and decision on medical treatment by CM (date prior to inclusion)
  • medical assessment of an acceptable surgical risk
  • patient affiliated to or beneficiary of a social security system
  • patient having freely signed the written informed consent

Exclusion

  • severe cognitive or mental disorders
  • severe and unstabilized eating behavior disorders
  • dependence on alcohol and licit and illicit psychoactive substances
  • illnesses endangering life in the short and medium term
  • contraindications to general anesthesia
  • absence of identified prior medical care and foreseeable inability of the patient to participate in lifelong medical monitoring
  • history of bariatric surgery
  • pregnant or breastfeeding woman, or having a very long-term pregnancy plan short term (\< 2 years)
  • adult patient under guardianship or curatorship
  • patient deprived of liberty or under judicial decision

Key Trial Info

Start Date :

July 3 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2032

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06600555

Start Date

July 3 2024

End Date

December 1 2032

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medipole Lyon Villeurbanne

Villeurbanne, France, 69100

Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes | DecenTrialz